Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report) has earned an average rating of “Moderate Buy” from the ten analysts that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $36.56.

SGRY has been the topic of several research reports. Bank of America initiated coverage on shares of Surgery Partners in a report on Monday, December 16th. They issued a “buy” rating and a $30.00 price target on the stock. KeyCorp assumed coverage on shares of Surgery Partners in a report on Friday, October 11th. They set a “sector weight” rating for the company. Macquarie restated an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research report on Tuesday, November 19th. Royal Bank of Canada reduced their price objective on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research note on Wednesday, November 20th. Finally, UBS Group began coverage on Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock.

View Our Latest Stock Report on SGRY

Surgery Partners Trading Down 2.7 %

NASDAQ:SGRY opened at $20.65 on Wednesday. The company has a market capitalization of $2.62 billion, a P/E ratio of -43.02, a PEG ratio of 17.40 and a beta of 2.58. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. Surgery Partners has a 12 month low of $19.50 and a 12 month high of $35.29. The firm has a fifty day simple moving average of $23.00 and a 200-day simple moving average of $27.36.

Surgery Partners (NASDAQ:SGRYGet Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analysts’ expectations of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business’s revenue was up 14.3% on a year-over-year basis. During the same quarter last year, the business earned $0.15 EPS. On average, equities research analysts anticipate that Surgery Partners will post 0.71 earnings per share for the current year.

Hedge Funds Weigh In On Surgery Partners

A number of large investors have recently bought and sold shares of SGRY. Arizona State Retirement System grew its holdings in Surgery Partners by 1.9% in the second quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock valued at $464,000 after purchasing an additional 359 shares during the period. Natixis Advisors LLC grew its stake in Surgery Partners by 3.0% in the 3rd quarter. Natixis Advisors LLC now owns 12,828 shares of the company’s stock valued at $414,000 after acquiring an additional 376 shares during the period. KBC Group NV increased its holdings in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after acquiring an additional 576 shares in the last quarter. Mackenzie Financial Corp raised its position in Surgery Partners by 3.4% during the second quarter. Mackenzie Financial Corp now owns 19,999 shares of the company’s stock worth $476,000 after acquiring an additional 662 shares during the period. Finally, Pier Capital LLC lifted its holdings in Surgery Partners by 0.5% during the third quarter. Pier Capital LLC now owns 329,882 shares of the company’s stock valued at $10,635,000 after purchasing an additional 1,589 shares in the last quarter.

About Surgery Partners

(Get Free Report

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Recommended Stories

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.